Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Knight

Showing results (451-460 of 453) with videos related to

Pageof 46
Sort By:
You have reached the last page of results.This site can display upto 453 results.
Neurology. Genetics|November 3, 2025
Motor Function in Limb-Girdle Muscular Dystrophy R1/2A: Validation of Clinical Outcome Assessments for Clinical Care and Trial ReadinessMeredith K James, Megan A Iammarino, Natalie F Reash, et al.
Cancer Research|October 5, 2001
The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancerD W Rusnak, K Affleck, S G Cockerill, et al.
The European Respiratory Journal|March 15, 2023
Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVIDNicholas A Scott, Laurence Pearmain, Sean B Knight, et al.
Pageof 46

Showing results (451-460 of 453) with videos related to

Sort By:
Pageof 46
You have reached the last page of results.This site can display upto 453 results.
Neurology. Genetics|November 3, 2025
Motor Function in Limb-Girdle Muscular Dystrophy R1/2A: Validation of Clinical Outcome Assessments for Clinical Care and Trial ReadinessMeredith K James, Megan A Iammarino, Natalie F Reash, et al.
Cancer Research|October 5, 2001
The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancerD W Rusnak, K Affleck, S G Cockerill, et al.
The European Respiratory Journal|March 15, 2023
Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVIDNicholas A Scott, Laurence Pearmain, Sean B Knight, et al.
Pageof 46